{"id":"https://openalex.org/W1964478407","doi":"https://doi.org/10.1089/dia.2005.7.467","title":"Exenatide Improves Glycemic Control and Reduces Body Weight in Subjects with Type 2 Diabetes: A Dose-Ranging Study","display_name":"Exenatide Improves Glycemic Control and Reduces Body Weight in Subjects with Type 2 Diabetes: A Dose-Ranging Study","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W1964478407","doi":"https://doi.org/10.1089/dia.2005.7.467","mag":"1964478407","pmid":"https://pubmed.ncbi.nlm.nih.gov/15929678"},"language":"en","primary_location":{"id":"doi:10.1089/dia.2005.7.467","doi":"https://doi.org/10.1089/dia.2005.7.467","is_oa":false,"landing_page_url":"https://doi.org/10.1089/dia.2005.7.467","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964478407"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108497778","display_name":"Terri Poon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terri Poon","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, California","Amylin Pharmaceuticals Inc, San Diego, California 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, California","institution_ids":[]},{"raw_affiliation_string":"Amylin Pharmaceuticals Inc, San Diego, California 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020475314","display_name":"Patric Nelson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patric Nelson","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113725447","display_name":"Larry Zaiqian Shen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larry Shen","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110563793","display_name":"Michael J. Mihm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Mihm","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110734241","display_name":"Kristin Taylor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristin Taylor","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083503351","display_name":"Mark S. Fineman","orcid":"https://orcid.org/0000-0002-9883-6847","observed_orcids":["https://orcid.org/0000-0002-9883-6847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Fineman","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007758632","display_name":"Dennis S. Kim","orcid":"https://orcid.org/0000-0002-5707-2609","observed_orcids":["https://orcid.org/0000-0002-5707-2609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis Kim","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, California","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.1488,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.98354146,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"7","issue":"3","first_page":"467","last_page":"477"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8740000128746033},{"id":"https://openalex.org/keywords/incretin-mimetics","display_name":"incretin mimetics","score":0.9909999966621399},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9039999842643738},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9670000076293945},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.871999979019165},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8970000147819519},{"id":"https://openalex.org/keywords/dose-dependence","display_name":"dose dependence","score":0.7300000190734863},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8880000114440918},{"id":"https://openalex.org/keywords/diet-and-exercise","display_name":"diet and exercise","score":0.9210000038146973},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.8100000023841858},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6119999885559082},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.31299999356269836},{"id":"https://openalex.org/keywords/vomiting","display_name":"vomiting","score":0.42500001192092896},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.7179999947547913},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5329999923706055},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8420000076293945},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9821286797523499},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9195054173469543},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7908636331558228},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7334115505218506},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7108702063560486},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6814438104629517},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6534237265586853},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6446728706359863},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.6162853837013245},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5297345519065857},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48626482486724854},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41128334403038025},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.10435229539871216},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044469","descriptor_name":"Racial Groups","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/dia.2005.7.467","doi":"https://doi.org/10.1089/dia.2005.7.467","is_oa":false,"landing_page_url":"https://doi.org/10.1089/dia.2005.7.467","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:15929678","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15929678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes technology & therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1909310469","https://openalex.org/W1910418518","https://openalex.org/W1971981454","https://openalex.org/W1973351394","https://openalex.org/W1980331056","https://openalex.org/W1983464930","https://openalex.org/W1984740259","https://openalex.org/W1987682269","https://openalex.org/W1996441843","https://openalex.org/W2000366267","https://openalex.org/W2006973534","https://openalex.org/W2014816693","https://openalex.org/W2015950058","https://openalex.org/W2016431637","https://openalex.org/W2023381928","https://openalex.org/W2028515800","https://openalex.org/W2056726092","https://openalex.org/W2065867087","https://openalex.org/W2069150029","https://openalex.org/W2077149049","https://openalex.org/W2101613382","https://openalex.org/W2101718966","https://openalex.org/W2102319947","https://openalex.org/W2109069837","https://openalex.org/W2115707749","https://openalex.org/W2121894019","https://openalex.org/W2122686314","https://openalex.org/W2125186811","https://openalex.org/W2127119840","https://openalex.org/W2127409471","https://openalex.org/W2131669718","https://openalex.org/W2132259774","https://openalex.org/W2132308332","https://openalex.org/W2136254957","https://openalex.org/W2145276190","https://openalex.org/W2146232529","https://openalex.org/W2154909966","https://openalex.org/W2156184369","https://openalex.org/W2162934281","https://openalex.org/W2169760435","https://openalex.org/W2169775081","https://openalex.org/W2172082596","https://openalex.org/W2320006945","https://openalex.org/W2337454357","https://openalex.org/W2400689952","https://openalex.org/W2752336761","https://openalex.org/W2977629971","https://openalex.org/W4252564070","https://openalex.org/W4254177295"],"related_works":["https://openalex.org/W2005582534","https://openalex.org/W1984740259","https://openalex.org/W1985739127","https://openalex.org/W1972204120","https://openalex.org/W2058563527","https://openalex.org/W2135743107","https://openalex.org/W2974011125","https://openalex.org/W3192357907","https://openalex.org/W2062883844"],"abstract_inverted_index":{"BACKGROUND:":[0],"Exenatide":[1,26,309],"is":[2],"the":[3,20,60,64,302],"first":[4],"of":[5,9,22,63,69,120,294,305],"a":[6],"new":[7],"class":[8],"agents":[10],"known":[11],"as":[12,42,44],"incretin":[13],"mimetics":[14],"that":[15,290],"are":[16],"in":[17,36,48,80,135,175,233,321],"development":[18],"for":[19,113,154,196,215,253,268],"treatment":[21],"type":[23,39,83,324],"2":[24,40,84,93,325],"diabetes.":[25,85],"has":[27],"been":[28],"shown":[29],"to":[30,58,73,100,298],"reduce":[31],"fasting":[32,176],"and":[33,67,75,150,156,160,166,191,198,202,220,248,255,259,270,314],"postprandial":[34],"glucose":[35,178],"patients":[37,81,97,216,227,296,322],"with":[38,82,125,218,223,277,323,328],"diabetes,":[41],"well":[43],"provide":[45],"sustained":[46],"reductions":[47,134,174,212,232],"hemoglobin":[49],"A":[50],"1c":[51,137],"(HbA":[52],"1c).":[53],"This":[54],"study":[55,303],"was":[56,123,287,291],"designed":[57],"assess":[59],"dose":[61],"dependencies":[62],"glucoregulatory":[65],"effects":[66],"tolerability":[68],"exenatide":[70,103,122,229,274,299],"when":[71],"added":[72],"diet":[74],"exercise":[76],"or":[77,102,108,330],"metformin":[78],"monotherapy":[79],"METHODS:":[86],"In":[87,225],"this":[88],"randomized,":[89],"triple-blinded,":[90],"placebo-controlled":[91],"Phase":[92],"clinical":[94],"trial,":[95],"156":[96],"were":[98,213],"randomized":[99,297],"placebo":[101,155,197,254],"at":[104,279],"2.5,":[105,157,199,256],"5.0,":[106,158,200,257],"7.5,":[107,159,201,258],"10.0":[109,161,203,260,271],"microg":[110,162,204,261,272],"administered":[111],"b.i.d.":[112,163,205,262,273],"28":[114,118,319],"days.":[115],"RESULTS:":[116],"After":[117],"days":[119,320],"therapy,":[121],"associated":[124],"significant":[126,167],"(P":[127,168],"<":[128,266],"0.0001,":[129],"linear":[130,171],"contrast":[131,172],"testing),":[132],"dose-dependent":[133,231,292],"HbA":[136],"(0.1":[138],"+/-":[139,142,145,148,152,180,183,186,189,193,237,240,243,246,250],"0.1%,":[140,143,146],"-0.3":[141],"-0.4":[144],"+/-0.5":[147],"0.0%,":[149],"-0.5":[151],"0.1%":[153],"exenatide,":[164,206,263],"respectively)":[165,207],"=":[169],"0.0006,":[170],"testing)":[173],"plasma":[177],"(+6.8":[179],"4.1,":[181],"-20.1":[182],"5.2,":[184],"-21.2":[185],"3.9,":[187],"-17.7":[188],"4.8,":[190],"-17.3":[192],"4.4":[194],"mg/dL":[195],"by":[208],"Day":[209,280],"28.":[210,281],"These":[211],"similar":[214],"treated":[217,222,327],"diet/exercise":[219,329],"those":[221],"metformin.":[224,331],"addition,":[226],"receiving":[228],"exhibited":[230],"body":[234,316],"weight":[235,317],"(0.0":[236],"0.3,":[238,241,247],"-0.7":[239,242],"0.2,":[244],"-1.4":[245],"-1.8":[249],"0.3":[251],"kg":[252],"respectively;":[264],"P":[265],"0.01":[267],"7.5":[269],"doses":[275],"compared":[276],"placebo)":[278],"The":[282],"most":[283],"common":[284],"adverse":[285],"event":[286],"mild-to-moderate":[288],"nausea":[289],"(seven":[293],"123":[295],"withdrew":[300],"from":[301],"because":[304],"gastrointestinal":[306],"effects).":[307],"CONCLUSIONS:":[308],"dose-dependently":[310],"improved":[311],"glycemic":[312],"control":[313],"reduced":[315],"over":[318],"diabetes":[326]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964478407","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
